English
/
中文
HOME
Home
WHO WE ARE
Nav
WHAT WE DO
Nav
INVESTORS
Nav
PIPELINE
Nav
NEWS
Nav
CAREERS
Nav
CONTACT US
Nav
HISTORY
LEADERSHIP
ADVISORS
BOARD OF DIRECTORS
Fontacea was invited to participate in the "ICBC Cup · Shanghai Lingang Innovative Design and Entrep
[ news ]
2021-05-19
Fontacea and Thousand Oaks reach strategic cooperation
[ news ]
2021-04-13
Fontacea takes action in promoting the R&D and innovation of Chinese biomedicine
[ news ]
2020-12-21
Fontacea supports Guzhang through alleviating poverty
[ news ]
2020-06-24
"Innovate together to win the future" Fontacea successfully held the launch ceremony in Shenzhen
[ news ]
2020-04-12
Mr Yanliang Chu, chairman of Fontacea, signed Dr David Brooks as business consultant in USA
[ news ]
2020-02-10
Mr Yanliang Chu, Chairman of Fontacea, signed Dr Timothy P. Coogan as the Medicine Safety Consultant
[ news ]
2019-12-23
Senior leaders attended "Innovative Medicine Investment Seminar"
[ news ]
2019-12-11
Shandong Fontacea is licensed for anti-IL17A monoclonal antibody from Janssen
[ news ]
2019-09-10
Yanliang Chu, welcomes Mark Winnett as Management Consultant to Fontacea
[ news ]
2019-08-12
Fontacea shareholder Lei Meng, chairman of Shandong development investment holding group co. LTD
[ news ]
2019-07-17
to the end ~
